Skip to main content
Clinical Trials/RBR-10tn82jt
RBR-10tn82jtRecruiting未知

Detection of silicone oil from the syringe in the vitreous of patients undergoing intravitreal injection: a double-blind randomized clinical trial

Hospital de Olhos de Sergipe0 sitesStarted: October 18, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

The rate of eyes with silicone oil droplets detected in the vitreous will be reported in the comparison of the groups. Likewise, the rate of eyes with anterior chamber cells will be reported for both groups

Study Design

Study Type
Intervention

Eligibility Criteria

Ages
18Y to 0 (—)

Inclusion Criteria

  • Over 18 years of age; both sexes; diabetic retinopathy, with indication for intravitreal injection of bevacizumab; clear ocular media and adequate pupillary dilation in both eyes to allow for all imaging procedures; visual acuity between 20/25 and 20/400; provide written consent; availability to come for exam 3 days after first injection and monthly for new exams and injection for 6 months

Exclusion Criteria

  • Severe glaucoma; age-related macular degeneration or retinal dystrophy; previous or current history of uveitis; previous vitreoretinal surgery; systemic contraindication to antiangiogenic therapy; presence of intraocular inflammation; any intraocular surgery in the previous 3 months; any eye infection; pregnancy or breastfeeding; any of the following conditions: severe heart disease, significant peripheral vascular disease; stroke in the last 6 months

Investigators

Sponsor
Hospital de Olhos de Sergipe

Similar Trials